All Stories

  1. Neutrophil–lymphocyte ratio being associated with mortality risk in patients receiving antifibrotic therapy

    Article • Respiratory Medicine, March 2024, Elsevier

    Yuzo Suzuki

  2. CD109 Attenuates Bleomycin-induced Pulmonary Fibrosis by Inhibiting TGF-β Signaling

    Article • The Journal of Immunology, February 2024, The American Association of Immunologists

    Yuzo Suzuki

  3. Neutrophil–lymphocyte ratio in patients with idiopathic pleuroparenchymal fibroelastosis

    Article • BMJ Open Respiratory Research, December 2023, BMJ

    Yuzo Suzuki

  4. Standardized 3D-CT lung volumes for patients with acute exacerbation of rheumatoid arthritis-associated interstitial lung disease

    Article • Rheumatology, July 2023, Oxford University Press (OUP)

    Yuzo Suzuki

  5. Geriatric Nutritional Risk Index is a predictor of tolerability of antifibrotic therapy and mortality risk in patients with idiopathic pulmonary fibrosis

    Article • Respirology, May 2023, Wiley

    Yuzo Suzuki

  6. Assessment of malnutrition-related risk in patients with idiopathic pleuroparenchymal fibroelastosis

    Article • ERJ Open Research, March 2023, European Respiratory Society (ERS)

    Yuzo Suzuki

  7. CD109 on Dendritic Cells Regulates Airway Hyperreactivity and Eosinophilic Airway Inflammation

    Article • American Journal of Respiratory Cell and Molecular Biology, February 2023, American Thoracic Society

    Yuzo Suzuki

  8. Treatments of refractory eosinophilic lung diseases with biologics

    Article • Allergology International, January 2023, Elsevier

    Yuzo Suzuki

  9. Clinical practice of high-flow nasal cannula therapy in COVID-19 pandemic era: a cross-sectional survey of respiratory physicians

    Article • Respiratory Investigation, November 2022, Elsevier

    Yuzo Suzuki

  10. Effect of Hypoxia on Pulmonary Endothelial Cells from Bleomycin-Induced Pulmonary Fibrosis Model Mice

    Article • International Journal of Molecular Sciences, August 2022, MDPI AG

    Yuzo Suzuki

  11. Idiopathic pleuroparenchymal fibroelastosis: 3-D CT assessment of upper lobe lung volume

    Article • European Respiratory Journal, July 2022, European Respiratory Society (ERS)

    Yuzo Suzuki

  12. Standardised 3D-CT lung volumes for patients with idiopathic pulmonary fibrosis

    Article • June 2022, Springer Science + Business Media

    Yuzo Suzuki

  13. Impact of end-of-life respiratory modalities on quality of dying and death and symptom relief in patients with interstitial lung disease: a multicenter descriptive cross-sectional study

    Article • April 2022, Springer Science + Business Media

    Yuzo Suzuki

  14. Impact of antifibrotic therapy on lung cancer development in idiopathic pulmonary fibrosis

    Article • Thorax, March 2022, BMJ

    Yuzo Suzuki

  15. Involvement of autophagy in exacerbation of eosinophilic airway inflammation in a murine model of obese asthma

    Article • Autophagy, January 2022, Taylor & Francis

    Yuzo Suzuki

  16. Combined assessment of the GAP index and body mass index at antifibrotic therapy initiation for prognosis of idiopathic pulmonary fibrosis

    Article • Scientific Reports, September 2021, Springer Science + Business Media

    Yuzo Suzuki

  17. Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort study

    Article • BMC Pulmonary Medicine, July 2021, Springer Science + Business Media

    Yuzo Suzuki

  18. Prognostic and Clinical Value of Cluster Analysis in Idiopathic Pleuroparenchymal Fibroelastosis Phenotypes

    Article • Journal of Clinical Medicine, April 2021, MDPI AG

    Yuzo Suzuki

  19. Quality of dying and death in patients with interstitial lung disease compared with lung cancer: an observational study

    Article • Thorax, December 2020, BMJ

    Yuzo Suzuki

  20. Cause of mortality and sarcopenia in patients with idiopathic pulmonary fibrosis receiving antifibrotic therapy

    Article • Respirology, September 2020, Wiley

    Yuzo Suzuki

  21. Disease course and prognosis of pleuroparenchymal fibroelastosis compared with idiopathic pulmonary fibrosis

    Article • Respiratory Medicine, September 2020, Elsevier

    Yuzo Suzuki

  22. Erlotinib and bevacizumab in elderly patients ≥75 years old with non-small cell lung cancer harboring epidermal growth factor receptor mutations

    Article • Investigational New Drugs, August 2020, Springer Science + Business Media

    Yuzo Suzuki

  23. Pneumothorax in connective tissue disease-associated interstitial lung disease

    Article • PLOS One, July 2020, PLOS

    Yuzo Suzuki, Dr. Tomoyuki Fujisawa

  24. Comprehensive assessment of multiple tryptophan metabolites as potential biomarkers for immune checkpoint inhibitors in patients with non-small cell lung cancer

    Article • Revista de Oncología, June 2020, Springer Science + Business Media

    Yuzo Suzuki

  25. Palliative Care for Idiopathic Pulmonary Fibrosis Patients: Pulmonary Physicians' View

    Article • Journal of Pain and Symptom Management, June 2020, Elsevier

    Yuzo Suzuki

  26. Imaging mass spectrometry to visualise increased acetylcholine in lungs of asthma model mice

    Article • Analytical and Bioanalytical Chemistry, May 2020, Springer Science + Business Media

    Yuzo Suzuki

  27. Intravoxel incoherent motion magnetic resonance imaging for predicting the long-term efficacy of immune checkpoint inhibitors in patients with non-small-cell lung cancer

    Article • Lung Cancer, May 2020, Elsevier

    Yuzo Suzuki

  28. Assessment of Immune-Related Interstitial Lung Disease in Patients With NSCLC Treated with Immune Checkpoint Inhibitors: A Multicenter Prospective Study

    Article • Journal of Thoracic Oncology, April 2020, Elsevier

    Yuzo Suzuki

  29. Quantitative computed tomography measures of skeletal muscle mass in patients with idiopathic pulmonary fibrosis according to a multidisciplinary discussion diagnosis: A retrospective nationwide study in Japan

    Article • Respiratory Investigation, March 2020, Elsevier

    Yuzo Suzuki

  30. Author Correction: Macrophage Mannose Receptor CD206 Predicts Prognosis in Community-acquired Pneumonia

    Article • Scientific Reports, February 2020, Springer Science + Business Media

    Yuzo Suzuki

  31. Paraneoplastic Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Should Be Treated with Low-dose Prednisolone During Pembrolizumab Therapy: The Authors' Reply

    Article • Internal Medicine, February 2020, Japanese Society of Internal Medicine

    Yuzo Suzuki

  32. CD200 and CD200R1 are differentially expressed and have differential prognostic roles in non-small cell lung cancer

    Article • OncoImmunology, January 2020, Taylor & Francis

    Yuzo Suzuki

  33. Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis

    Article • Therapeutic Advances in Respiratory Disease, January 2020, SAGE Publications

    Yuzo Suzuki

  34. Pulse oximetric saturation to fraction of inspired oxygen (SpO2/FIO2) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung disease

    Article • Therapeutic Advances in Respiratory Disease, January 2020, SAGE Publications

    Yuzo Suzuki

  35. A GWAS approach identifies Dapp1 as a determinant of air pollution-induced airway hyperreactivity

    Article • PLoS Genetics, December 2019, PLOS

    Yuzo Suzuki

  36. Macrophage Mannose Receptor CD206 Predicts Prognosis in Community-acquired Pneumonia

    Article • Scientific Reports, December 2019, Springer Science + Business Media

    Yuzo Suzuki

  37. Simultaneous Occurrence of Sarcoidosis and Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis in a Patient with Lung Cancer

    Article • Internal Medicine, November 2019, Japanese Society of Internal Medicine

    Yuzo Suzuki

  38. Synchronous Occurrence of Bazex Syndrome and Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome in a Patient with Lung Cancer

    Article • Internal Medicine, November 2019, Japanese Society of Internal Medicine

    Yuzo Suzuki

  39. Prognostic factors for primary Sjögren's syndrome-associated interstitial lung diseases

    Article • Respiratory Medicine, November 2019, Elsevier

    Yuzo Suzuki

  40. Prognostic impact of an early marginal decline in forced vital capacity in idiopathic pulmonary fibrosis patients treated with pirfenidone

    Article • Respiratory Investigation, November 2019, Elsevier

    Yuzo Suzuki

  41. Clinical significance of serum S100 calcium‐binding protein A4 in idiopathic pulmonary fibrosis

    Article • Respirology, October 2019, Wiley

    Yuzo Suzuki

  42. Body composition changes successfully classify prognosis in patients with mycobacterium avium complex lung disease

    Article • Journal of Infection, October 2019, Elsevier

    Yuzo Suzuki

  43. Eosinophilic pneumonia: A review of the previous literature, causes, diagnosis, and management

    Article • Allergology International, October 2019, Elsevier

    Yuzo Suzuki

  44. Once-daily fluticasone furoate/vilanterol combination versus twice-daily budesonide/formoterol combination in the treatment of controlled stable asthma: a randomized crossover trial

    Article • Journal of Asthma and Allergy, September 2019, Taylor & Francis

    Dr. Tomoyuki Fujisawa, Yuzo Suzuki

  45. Effect of PD-1 inhibitor on exhaled nitric oxide and pulmonary function in non-small cell lung cancer patients with and without COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, August 2019, Taylor & Francis

    Yuzo Suzuki, Dr. Tomoyuki Fujisawa

  46. Heterogeneity analysis of PD-L1 expression and copy number status in EBUS-TBNA biopsy specimens of non-small cell lung cancer: Comparative assessment of primary and metastatic sites

    Article • Lung Cancer, August 2019, Elsevier

    Yuzo Suzuki

  47. Analysis of serum adiponectin and leptin in patients with acute exacerbation of idiopathic pulmonary fibrosis

    Article • Scientific Reports, July 2019, Springer Science + Business Media

    Yuzo Suzuki

  48. Frequency and clinical relevance of anti-cyclic citrullinated peptide antibody in idiopathic interstitial pneumonias

    Article • Respiratory Medicine, July 2019, Elsevier

    Yuzo Suzuki

  49. Clinical features of three-dimensional computed tomography-based radiologic phenotypes of chronic obstructive pulmonary disease

    Article • International Journal of Chronic Obstructive Pulmonary Disease, June 2019, Dove Medical Press

    Yuzo Suzuki, Dr. Tomoyuki Fujisawa

  50. CD206 classify prognosis in patients with MDA5-DM-ILD

    Article • Rheumatology, May 2019, Oxford University Press (OUP)

    Yuzo Suzuki

  51. Physiological and morphological differences of airways between COPD and asthma–COPD overlap

    Article • Scientific Reports, May 2019, Springer Science + Business Media

    Yuzo Suzuki

  52. Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody–positive Dermatomyositis-associated Interstitial Lung Disease

    Article • The Journal of Rheumatology, May 2019, The Journal of Rheumatology

    Yuzo Suzuki

  53. Olanzapine-containing antiemetic therapy for the prevention of carboplatin-induced nausea and vomiting

    Article • Cancer Chemotherapy and Pharmacology, May 2019, Springer Science + Business Media

    Yuzo Suzuki

  54. Methotrexate-associated Lymphoproliferative Disorder with Diffuse Ground-Glass Opacities

    Article • American Review of Respiratory Disease, April 2019, American Thoracic Society

    Yuzo Suzuki

  55. Nationwide cloud-based integrated database of idiopathic interstitial pneumonias for multidisciplinary discussion

    Article • European Respiratory Journal, March 2019, European Respiratory Society (ERS)

    Dr. Tomoyuki Fujisawa, Yuzo Suzuki

  56. Efficacy of corticosteroid and intravenous cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A propensity score‐matched analysis

    Article • Respirology, February 2019, Wiley

    Yuzo Suzuki

  57. Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma

    Article • Investigational New Drugs, February 2019, Springer Science + Business Media

    Yuzo Suzuki

  58. Efficacy of Glucocorticoids and Calcineurin Inhibitors for Anti-aminoacyl-tRNA Synthetase Antibody–positive Polymyositis/dermatomyositis–associated Interstitial Lung Disease: A Propensity Score–matched Analysis

    Article • The Journal of Rheumatology, January 2019, The Journal of Rheumatology

    Yuzo Suzuki

  59. Correlation of the modified Medical Research Council dyspnea scale with airway structure assessed by three-dimensional CT in patients with chronic obstructive pulmonary disease

    Article • Respiratory Medicine, January 2019, Elsevier

    Yuzo Suzuki

  60. An Acquired Epidermal Growth Factor Receptor T790M Mutation after the Addition of Bevacizumab to Preceding Erlotinib Monotherapy in a Lung Cancer Patient with Leptomeningeal Metastases

    Article • Internal Medicine, December 2018, Japanese Society of Internal Medicine

    Yuzo Suzuki

  61. Differences in airway structural changes assessed by 3-dimensional computed tomography in asthma and asthma–chronic obstructive pulmonary disease overlap

    Article • Annals of Allergy Asthma & Immunology, December 2018, Elsevier

    Yuzo Suzuki

  62. Differences in clinical features of acute exacerbation between connective tissue disease-associated interstitial pneumonia and idiopathic pulmonary fibrosis

    Article • Chronic Respiratory Disease, October 2018, SAGE Publications

    Yuzo Suzuki

  63. Cachexia is associated with prognosis in IPF and PPFE.

    Article • Scientific Reports, September 2018, Springer Science + Business Media

    Yuzo Suzuki

  64. IL-17A Attenuates IFN-λ Expression by Inducing Suppressor of Cytokine Signaling Expression in Airway Epithelium

    Article • The Journal of Immunology, September 2018, The American Association of Immunologists

    Yuzo Suzuki

  65. Prophylactic aprepitant is better than salvage for carboplatin-based chemotherapy: a propensity score-matched analysis

    Article • Medical Oncology, September 2018, Springer Science + Business Media

    Yuzo Suzuki

  66. Macrophage mannose receptor, CD206, predict prognosis in patients with pulmonary tuberculosis

    Article • Scientific Reports, September 2018, Springer Science + Business Media

    Yuzo Suzuki

  67. Prognostic evaluation of serum ferritin in acute exacerbation of idiopathic pulmonary fibrosis

    Article • The Clinical Respiratory Journal, August 2018, Wiley

    Yuzo Suzuki

  68. How to manage the CEP patients.

    Article • Allergology International, July 2018, Elsevier

    Yuzo Suzuki

  69. Changes in pulmonary endothelial cell properties during bleomycin-induced pulmonary fibrosis

    Article • June 2018, Springer Science + Business Media

    Yuzo Suzuki

  70. Clinical significance of myeloperoxidase-anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonias

    Article • PLOS One, June 2018, PLOS

    Yuzo Suzuki

  71. Switch maintenance therapy with docetaxel and bevacizumab after induction therapy with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous non-small cell lung cancer: a phase II study

    Article • Medical Oncology, June 2018, Springer Science + Business Media

    Yuzo Suzuki

  72. Asperhillus-Ag predicts AE-COPD and prognosis in patients with COPD.

    Article • PLOS One, June 2018, PLOS

    Yuzo Suzuki

  73. Neutrophil gelatinase-associated lipocalin in patients with sarcoidosis

    Article • Respiratory Medicine, May 2018, Elsevier

    Yuzo Suzuki

  74. Distinctive characteristics and prognostic significance of interstitial pneumonia with autoimmune features in patients with chronic fibrosing interstitial pneumonia

    Article • Respiratory Medicine, April 2018, Elsevier

    Yuzo Suzuki

  75. Respiratory impedance is correlated with airway narrowing in asthma using three-dimensional computed tomography

    Article • Clinical & Experimental Allergy, February 2018, Wiley

    Yuzo Suzuki

  76. Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: A retrospective multicenter study

    Article • Respiratory Medicine, December 2017, Elsevier

    Yuzo Suzuki

  77. This article revealed the risk factors associated with feature risks of PFT impairment.

    Article • Annals of Allergy Asthma & Immunology, November 2017, Elsevier

    Yuzo Suzuki

  78. Relationship between fraction of exhaled nitric oxide and airway morphology assessed by three-dimensional CT analysis in asthma

    Article • Scientific Reports, August 2017, Springer Science + Business Media

    Yuzo Suzuki

  79. Body size-adjusted dose analysis of pirfenidone in patients with interstitial pneumonia

    Article • Respirology, August 2017, Wiley

    Yuzo Suzuki

  80. Clinical Utility of YKL-40 in Polymyositis/dermatomyositis-associated Interstitial Lung Disease

    Article • The Journal of Rheumatology, July 2017, The Journal of Rheumatology

    Yuzo Suzuki

  81. Respiratory impedance is correlated with morphological changes in the lungs on three-dimensional CT in patients with COPD

    Article • Scientific Reports, February 2017, Springer Science + Business Media

    Yuzo Suzuki

  82. Evaluation of urinary desmosines as a noninvasive diagnostic biomarker in patients with idiopathic pleuroparenchymal fibroelastosis (PPFE)

    Article • Respiratory Medicine, February 2017, Elsevier

    Yuzo Suzuki

  83. sCD163 in PM/DM-ILD

    Article • January 2017, Springer Science + Business Media

    Yuzo Suzuki

  84. Synchronous Duodenal Cancer and Lung Cancer Harboring an Epidermal Growth Factor Receptor Mutation Treated with Erlotinib and Oral Fluoropyrimidine

    Article • Internal Medicine, January 2017, Japanese Society of Internal Medicine

    Yuzo Suzuki

  85. Reply

    Article • Journal of Allergy and Clinical Immunology, November 2016, Elsevier

    Yuzo Suzuki

  86. Nicotine agonist attenuates ILC2 dependent AHR

    Article • Nature Communications, October 2016, Nature

    Yuzo Suzuki

  87. sCD163 in CAP

    Article • Journal of Infection, October 2016, Elsevier

    Yuzo Suzuki

  88. CD163 in TB

    Article • Annals of the American Thoracic Society, September 2016, American Thoracic Society

    Yuzo Suzuki

  89. Gastrointestinal Bleeding From Duodenal Aberrant Pancreas After Antiangiogenic Therapy

    Article • Journal of Clinical Gastroenterology, September 2016, Wolters Kluwer Health

    Yuzo Suzuki

  90. Morphological changes in small pulmonary vessels predicts AE-COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, June 2016, Dove Medical Press

    Yuzo Suzuki

  91. Incidences of TB in LK

    Article • Respiratory Investigation, May 2016, Elsevier

    Yuzo Suzuki

  92. Autophagy and Asthma

    Article • Journal of Allergy and Clinical Immunology, May 2016, Elsevier

    Yuzo Suzuki

  93. Impairment of Autophagy in Pulmonary CD11c+ Cells Induces Corticosteroid-Unresponsive Airway Hyperreactivity

    Article • Journal of Allergy and Clinical Immunology, February 2016, Elsevier

    Yuzo Suzuki

  94. ICOS:ICOS-Ligand Interaction Is Required for Type 2 Innate Lymphoid Cell Function, Homeostasis, and Induction of Airway Hyperreactivity

    Article • Immunity, March 2015, Elsevier

    Yuzo Suzuki

  95. Diffuse alveolar hemorrhage caused by exposure to organic dust

    Article • Respiratory Medicine Case Reports, January 2015, Elsevier

    Yuzo Suzuki

  96. Indoleamine 2,3-dioxygenase in TB pleurisy

    Article • The International Journal of Tuberculosis and Lung Disease, November 2013, International Union Against Tuberculosis and Lung Disease

    Yuzo Suzuki

  97. Association of Increased Indoleamine 2, 3-Dioxygenase With Impaired Natural Killer Cell Activity in Hemodialysis Patients

    Article • Therapeutic Apheresis and Dialysis, July 2013, Wiley

    Yuzo Suzuki

  98. KL-6 is associated with mortality in TB

    Article • The International Journal of Tuberculosis and Lung Disease, February 2013, International Union Against Tuberculosis and Lung Disease

    Yuzo Suzuki

  99. DLST is not useful in TB

    Article • The International Journal of Tuberculosis and Lung Disease, September 2012, International Union Against Tuberculosis and Lung Disease

    Yuzo Suzuki

  100. Lung DC subset and IgA

    Article • American Journal of Respiratory Cell and Molecular Biology, June 2012, American Thoracic Society

    Yuzo Suzuki

  101. Lung DC subset and T cell differentiations

    Article • American Journal of Respiratory Cell and Molecular Biology, February 2012, American Thoracic Society

    Yuzo Suzuki

  102. Indoleamine 2,3-Dioxygenase in TB

    Article • Clinical and Vaccine Immunology, January 2012, ASM Journals

    Yuzo Suzuki

  103. Indoleamine 2,3-dioxygenase in CAP

    Article • Journal of Infection, September 2011, Elsevier

    Yuzo Suzuki

  104. CD11bhigh Lung Dendritic Cells Are More Potent To Induce LGA Class Switch Recombination Than CD103+ Lung Dendritic Cells

    Article • May 2011, American Thoracic Society

    Yuzo Suzuki

  105. Serum Activity Of Indoleamine 2,3-Dioxygenase Predicts Prognosis Of Tuberculosis

    Article • May 2011, American Thoracic Society

    Yuzo Suzuki

  106. Indoleamine 2,3-dioxygenase in HD

    Article • Hemodialysis International, July 2010, Wiley

    Yuzo Suzuki

  107. Indoleamine 2,3-dioxygenase in LK

    Article • Lung Cancer, March 2010, Elsevier

    Yuzo Suzuki

  108. IVIG for PM/DM-ILD

    Article • Lung, April 2009, Springer Science + Business Media

    Yuzo Suzuki

  109. DLST in TB

    Article • CHEST Journal, November 2008, Elsevier

    Yuzo Suzuki